A detailed history of Cwm, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Cwm, LLC holds 548 shares of ARCT stock, worth $9,058. This represents 0.0% of its overall portfolio holdings.

Number of Shares
548
Previous 535 2.43%
Holding current value
$9,058
Previous $13,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$18.08 - $25.38 $235 - $329
13 Added 2.43%
548 $13,000
Q2 2024

Jul 09, 2024

SELL
$24.35 - $44.39 $194 - $355
-8 Reduced 1.47%
535 $13,000
Q1 2024

Apr 05, 2024

BUY
$31.23 - $42.99 $93 - $128
3 Added 0.56%
543 $18,000
Q4 2023

Feb 01, 2024

BUY
$17.71 - $32.97 $389 - $725
22 Added 4.25%
540 $17,000
Q3 2023

Oct 11, 2023

BUY
$25.44 - $37.35 $3,892 - $5,714
153 Added 41.92%
518 $13,000
Q2 2023

Aug 03, 2023

BUY
$23.94 - $32.36 $8,738 - $11,811
365 New
365 $10,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.